Research ArticleOriginal Article
Open Access

Identification of Candida species and susceptibility testing with Sensititre YeastOne microdilution panel to 9 antifungal agents

Emine Kucukates, Nuh N. Gultekin, Zeynep Alisan, Nur Hondur and Recep Ozturk
Saudi Medical Journal July 2016, 37 (7) 750-757; DOI: https://doi.org/10.15537/smj.2016.7.13412

References

  1. ↵
    1. Nadeem SG,
    2. Hakim ST,
    3. Kazmi SU
    (2010) Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited setting. Libyan J Med 5:1–6.
    OpenUrl
  2. ↵
    1. Madhavan P,
    2. Jamal F,
    3. Chong PP,
    4. Ng KP
    (2011) Identification of local clinical Candida isolates using CHROMagar Candida™ as a primary identification method for various Candida species. Trop Biomed 28:269–274.
    OpenUrlPubMed
  3. ↵
    1. Ramana KV,
    2. Kandi S,
    3. Venkata Bharatkumar P,
    4. Sharada CHV,
    5. Rao R,
    6. Mani R,
    7. et al.
    (2013) Invasive fungal infections: A comprehensive review. Am J Infect Dis and Microbiol 1:64–69.
    OpenUrl
  4. ↵
    1. Lewis RE,
    2. Viale P,
    3. Kontoyiannis DP
    (2012) The potential impact of antifungal drug resistance mechanisms on the host immune response to Candida. Virulence 3:368–376.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    1. Vijaya D,
    2. Harsa TR,
    3. Nagaatnamma T
    (2011) Candida specification using chrom agar. J Clin and Diagn Res 5:755–777.
    OpenUrl
  6. ↵
    1. Golia SK,
    2. Reddy KM,
    3. Karjigi S,
    4. Hittinahalli V
    (2013) Speciation of Candida using chromogenic and corn meal agar with determination of fluconazole sensitivity. Al Amen J Med Sci 6:163–166.
    OpenUrl
  7. ↵
    1. Bille E,
    2. Dauphin B,
    3. Leto J,
    4. Bougnoux ME,
    5. Beretti JL,
    6. Lotz A,
    7. et al.
    (2012) MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect 18:1117–1125.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Neppelenbroek KH,
    2. Seo RS,
    3. Urban VM,
    4. Silva S,
    5. Dovigo N,
    6. Jorge JH,
    7. et al.
    (2013) Identification of Candida species in the clinical laboratory: a review of conventional, commercial, and molecular techniques. Oral Dis 12:1–16.
    OpenUrl
  9. ↵
    1. Leon C,
    2. Ruiz-Santana S,
    3. Saavedra P,
    4. Galvan B,
    5. Blanco A,
    6. Castro C,
    7. et al.
    (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study. Crit Care Med 37:1624–1633.
    OpenUrlCrossRefPubMedWeb of Science
    1. Patolia S,
    2. Kennedy E,
    3. Zahir M,
    4. Patolia S,
    5. Gulati N,
    6. Narendra D,
    7. et al.
    (2013) Risk factors for Candida blood stream infection in medical ICU and role of colonization. A retrospective study. BJMP 6:a618–a623.
    OpenUrl
  11. ↵
    1. Lau AF,
    2. Kabir M,
    3. Chen SCA,
    4. Playford EG,
    5. Marriott DJ,
    6. Jones M,
    7. et al.
    (2015) Candida colonization as a risk marker for invasive candidiasis in mixed medical-surgical intensive care units: Development and evaluation of a simple, standard protocol. JCM 53:1324–1330.
    OpenUrl
  12. ↵
    1. Clinical and Laboratory Standards Institute (2007) References method for broth dilution antifungal susceptibility testing of yeasts;approved Standard M27-A3, 3rd ed
    Clinical and Laboratory Standards Institute, Wayne, PA.
  13. ↵
    1. Leon C,
    2. Ostrosky-Zeichner L,
    3. Schuster M
    (2014) What’s new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med 40:808–819.
    OpenUrlCrossRefPubMedWeb of Science
    1. Hankovszky P,
    2. Trasy D,
    3. Oveges N,
    4. Molnar Z
    (2015) Invasive Candida infections in the ICU: Diagnosis and therapy. J Crit Care Med 1:129–139.
    OpenUrl
    1. Gaspar GG,
    2. Menegueti MG,
    3. Auxiliadora-Martins M,
    4. Basile-Filho A,
    5. Martinez R
    (2015) Evaluation of the predictive indices for candidemia in an adult intensive care unit. Rev Soc Bras Med Trop 48:77–82.
    OpenUrl
    1. Delalo J,
    2. Calandra T
    (2014) Invasive candidiasis as a cause of sepsis in the critically ill patients. Virulence 5:161–169.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Ahmed A,
    2. Azim A,
    3. Baronia AK,
    4. Rungmei K,
    5. Marak SK,
    6. Gurjar M
    (2014) Risk prediction for invasive candidiasis. Ind J Crit Care Med 18:682–688.
    OpenUrl
  18. ↵
    1. Giri S,
    2. Kindo AJ,
    3. Kalyani J
    (2013) Candidemia in intensive care unit patients: A one year study from a tertiary care center in South India. JPGM 59:190–195.
    OpenUrl
    1. Flevari A,
    2. Theodorakopoulou M,
    3. Velegraki A,
    4. Armaganidis A,
    5. Dimopoulos G
    (2013) Treatment of invasive candidiasis in the elderly: a review. Clin Interventions in Aging 8:1199–1208.
    OpenUrl
  20. ↵
    1. Guimaraes T,
    2. Nucci M,
    3. Mendonça JS,
    4. Martinez R,
    5. Brito LR,
    6. Silva N,
    7. et al.
    (2012) Epidemiology and predictors of a poor outcome in elderly patients with candidemia. Int J Infect Dis 16:e442–e447.
    OpenUrlPubMed
  21. ↵
    1. Ostrosky-Zeichner L,
    2. Kullberg BJ,
    3. Bow EJ,
    4. Hadley S,
    5. Leon C,
    6. Nucci M,
    7. et al.
    (2011) Early treatment of candidemia in adults: a review. Med Mycol 49:113–120.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Vandeputte P,
    2. Ferrari S,
    3. Coste AT
    (2012) Antifungal resistance and new strategies to control fungal infections. Int J Microbiol 1:1–26.
    OpenUrl
  23. ↵
    1. Pfaller MA,
    2. Castanheira M,
    3. Lockhart SR,
    4. Ahlquist AM,
    5. Messer SA,
    6. Jones RN
    (2012) Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata. J Clin Microbiol 50:1199–1203.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Pfaller MA,
    2. Diekema DJ,
    3. Gibs DL,
    4. Newel VA,
    5. Ellis D,
    6. Tullio V,
    7. et al.,
    8. and the Global Antifungal Surveillance Group
    (2010) Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion. J Clin Microbiol 48:1366–1377.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Pfaller MA,
    2. Espinel-Ingroff A,
    3. Canton E,
    4. Castanheira M,
    5. Cuenca-Estrella M,
    6. Diekema DJ,
    7. et al.
    (2012) Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution. J Clin Microbiol 50:2040–2046.
    OpenUrlAbstract/FREE Full Text
    1. Ben-Ami R,
    2. Garcia Effron G,
    3. Lewis RE,
    4. Gamarra S,
    5. Leventakos K,
    6. Perlin DS,
    7. et al.
    (2011) Fitness and virulence costs of Candida albicans FKS1 hot spot mutations associated with echinocandin resistance. J Infect Dis 204:626–635.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Ben-Ami R,
    2. Kontoyiannis DP
    (2012) Resistance to echinocandins comes at a cost: the impact of FKS1 hot spot mutations on Candida albicans fitness and virulence. Virulence 3:95–97.
    OpenUrlCrossRefPubMed
  28. ↵
    1. Cıkman A,
    2. Parlak M,
    3. Ceylan MR,
    4. Guducuoglu H,
    5. Berktas M
    (2014) Antifungal susceptibility and distribution of Candida species isolated from various clinical specimens. Van Tıp Derg 21:1–5.
    OpenUrl
  29. ↵
    1. Kurtaran B,
    2. Inal AS,
    3. Candevir A,
    4. Kibar F,
    5. Tasova Y,
    6. Seydaoglu G,
    7. et al.
    (2009) Nosocomial Candida infections: microbiological and clinical features. Flora Derg 14:58–66.
    OpenUrl
    1. Ozbek E,
    2. Tekay F,
    3. Colak Pirinccioglu H
    (2012) Antifungal resistance of Candida isolates obtained from various specimens of intensive care unit patients. Dicle Tıp Derg 39:207–212.
    OpenUrl
  31. ↵
    1. Gulat S,
    2. Doluca Dereli M
    (2014) Investigation of the expression levels of efflux pumps in fluconazole resistant Candida albicans isolates. Mikrobiyol Bul 48:325–334.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section